Aspire Biopharma Holdings Inc (ASBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -328 | -231 | 4,464 | 4,615 | 4,684 |
| Other Working Capital | 79 | 38 | 687 | 441 | 241 |
| Other Operating Activity | 0 | 0 | -5,804 | -5,553 | -5,297 |
| Operating Cash Flow | $-249 | $-193 | $-653 | $-497 | $-372 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | 284,916 | 284,916 | 284,283 |
| Investing Cash Flow | $N/A | $N/A | $284,916 | $284,916 | $284,283 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 258 | 229 | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | -284,916 | -284,916 | -284,283 |
| Other Financing Activity | 0 | 0 | 156 | 0 | 0 |
| Financing Cash Flow | $258 | $229 | $-284,760 | $-284,916 | $-284,283 |
| Beginning Cash Position | 11 | 11 | 497 | 497 | 497 |
| End Cash Position | 20 | 47 | N/A | 0 | 125 |
| Net Cash Flow | $8 | $36 | $-497 | $-497 | $-372 |
| Free Cash Flow | |||||
| Operating Cash Flow | -249 | -193 | -653 | -497 | -372 |
| Free Cash Flow | -249 | -193 | -653 | -497 | -372 |